Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Asset Utilization Ratio (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.63 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 123.61% year-over-year to 0.63, compared with a TTM value of 0.63 through Sep 2025, up 123.61%, and an annual FY2024 reading of 0.3, up 65.79% over the prior year.
  • Asset Utilization Ratio was 0.63 for Q3 2025 at Arcadia Biosciences, up from 0.52 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.63 in Q3 2025 and bottomed at 0.13 in Q2 2023.
  • Average Asset Utilization Ratio over 5 years is 0.22, with a median of 0.24 recorded in 2024.
  • The sharpest move saw Asset Utilization Ratio crashed 135.99% in 2023, then surged 720.36% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.17 in 2021, then plummeted by 84.26% to 0.03 in 2022, then surged by 658.77% to 0.21 in 2023, then surged by 70.04% to 0.35 in 2024, then skyrocketed by 80.08% to 0.63 in 2025.
  • Business Quant data shows Asset Utilization Ratio for RKDA at 0.63 in Q3 2025, 0.52 in Q2 2025, and 0.4 in Q1 2025.